Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of -0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-20.78 Million ≈ $-5.22 Million USD) by net assets (RM489.50 Million ≈ $122.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View 7081 stock price and chart for real-time trading data and today's change.
Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)
This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Pharmaniaga Bhd (7081) market capitalisation for the company's overall valuation and market capitalisation.
Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency. Also see Pharmaniaga Bhd asset portfolio for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
First Bancorp Inc
NASDAQ:FNLC
|
0.078x |
|
Nanjing Aolian Ae&Ea Co Ltd
SHE:300585
|
0.027x |
|
The Anup Engineering Limited
NSE:ANUP
|
-0.098x |
|
Enseval Putra Megatrading Tbk
JK:EPMT
|
0.035x |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
-0.099x |
|
GDI Integrated
TO:GDI
|
0.066x |
|
K & S Corporation Ltd
AU:KSC
|
0.075x |
|
Lux Industries Limited
NSE:LUXIND
|
-0.130x |
Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)
The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. Review Pharmaniaga Bhd (7081) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | RM459.15 Million ≈ $115.28 Million |
RM-17.69 Million ≈ $-4.44 Million |
-0.039x | +86.82% |
| 2024-12-31 | RM-145.94 Million ≈ $-36.64 Million |
RM42.67 Million ≈ $10.71 Million |
-0.292x | -70.67% |
| 2023-12-31 | RM-274.09 Million ≈ $-68.81 Million |
RM46.95 Million ≈ $11.79 Million |
-0.171x | -141.92% |
| 2022-12-31 | RM-348.31 Million ≈ $-87.45 Million |
RM-142.34 Million ≈ $-35.74 Million |
0.409x | +400.12% |
| 2021-12-31 | RM470.44 Million ≈ $118.11 Million |
RM-64.06 Million ≈ $-16.08 Million |
-0.136x | -78.76% |
| 2020-12-31 | RM337.53 Million ≈ $84.74 Million |
RM-25.71 Million ≈ $-6.45 Million |
-0.076x | -113.56% |
| 2019-12-31 | RM337.85 Million ≈ $84.82 Million |
RM189.76 Million ≈ $47.64 Million |
0.562x | +449.59% |
| 2018-12-31 | RM509.34 Million ≈ $127.88 Million |
RM-81.83 Million ≈ $-20.55 Million |
-0.161x | -135.44% |
| 2017-12-31 | RM528.05 Million ≈ $132.57 Million |
RM239.41 Million ≈ $60.11 Million |
0.453x | +578.93% |
| 2016-12-31 | RM530.63 Million ≈ $133.22 Million |
RM35.44 Million ≈ $8.90 Million |
0.067x | +434.25% |
| 2015-12-31 | RM560.00 Million ≈ $140.60 Million |
RM7.00 Million ≈ $1.76 Million |
0.013x | -96.76% |
| 2014-12-31 | RM552.00 Million ≈ $138.59 Million |
RM213.00 Million ≈ $53.48 Million |
0.386x | -23.89% |
| 2013-12-31 | RM503.00 Million ≈ $126.29 Million |
RM255.00 Million ≈ $64.02 Million |
0.507x | +1355.27% |
| 2012-12-31 | RM488.00 Million ≈ $122.52 Million |
RM17.00 Million ≈ $4.27 Million |
0.035x | -- |
About Pharmaniaga Bhd
Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more